66.3 F
New York
Tuesday, May 28, 2024

Eli Lilly and Novo can 'coexist for awhile' in the weight-loss drug space, says BMO's Evan Seigerman

BusinessEli Lilly and Novo can 'coexist for awhile' in the weight-loss drug space, says BMO's Evan Seigerman



Evan Seigerman, BMO Capital, joins ‘Fast Money’ to discuss BMO’s inaugural GLP-1 conference.



Source link

Check out our other content

Check out other tags:

Most Popular Articles